MetLife Investment Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,091
| Closed | -$522K | – | 2841 |
|
|
2022
Q3 | $522K | Hold |
14,091
| – | – | ﹤0.01% | 1601 |
|
|
2022
Q2 | $268K | Hold |
14,091
| – | – | ﹤0.01% | 2104 |
|
|
2022
Q1 | $380K | Buy |
14,091
+7,337
| +109% | +$198K | ﹤0.01% | 1951 |
|
|
2021
Q4 | $152K | Hold |
6,754
| – | – | ﹤0.01% | 2222 |
|
|
2021
Q3 | $177K | Hold |
6,754
| – | – | ﹤0.01% | 2172 |
|
|
2021
Q2 | $216K | Hold |
6,754
| – | – | ﹤0.01% | 2119 |
|
|
2021
Q1 | $238K | Hold |
6,754
| – | – | ﹤0.01% | 1962 |
|
|
2020
Q4 | $217K | Hold |
6,754
| – | – | ﹤0.01% | 1943 |
|
|
2020
Q3 | $254K | Hold |
6,754
| – | – | ﹤0.01% | 1714 |
|
|
2020
Q2 | $302K | Buy |
+6,754
| New | +$302K | ﹤0.01% | 1650 |
|